Publications by authors named "Kogure Y"

ETV6::LYN fusion gene is recognized as one of the genetic alterations responsible for myeloid/lymphoid neoplasms with eosinophilia and tyrosine kinase gene fusions (MLN-TK) according to the 2022 WHO classification. However, the clinical features and pathogenesis of MLN-TK with ETV6::LYN are not well defined because of the rarity of the disease. Here, we report an MLN-TK patient with ETV6::LYN that manifested as myeloproliferative neoplasms (MPN) with eosinophilia, myelofibrosis, and T-lymphoblastic lymphoma (T-LBL), which eventually led to acute myeloid leukemia.

View Article and Find Full Text PDF

Transient abnormal myelopoiesis (TAM) generally affects newborns with Down syndrome and is associated with constitutional trisomy 21 and a somatic GATA1 mutation. Here we describe a case of TAM which evolved after umbilical cord blood transplantation (UCBT), whose origin was identified as a GATA1 mutation-harboring clone in umbilical cord blood (UCB) by detailed genetic analyses. A 58-year-old male who received UCBT for peripheral T-cell lymphoma presented progressive anemia and thrombocytopenia, and leukocytosis with blast cells in the peripheral blood (PB).

View Article and Find Full Text PDF

CD5 expression is seen in 5%-10% of de novo diffuse large B-cell lymphomas (DLBCLs). Primary large B-cell lymphoma of the central nervous system (PCNS-LBCL) also exhibits CD5 expression in a minority of cases, however, clinicopathological and molecular features remain largely unclarified. Here we present the clinical, molecular, and pathological features of 11 CD5-positive () PCNS-LBCL cases, occupying 6.

View Article and Find Full Text PDF

Introduction: Both combined endobronchial ultrasonography (EBUS) and transoesophageal bronchoscopic ultrasonography (EUS-B) and EBUS alone have been recommended for preoperative mediastinal staging of nonsmall cell lung cancer (NSCLC). However, no randomised study comparing these two methods has been published. The purpose of the present study was to compare the sensitivity of EBUS and that of combined EBUS and EUS-B (EBUS/EUS-B) in terms of detecting N2/N3 disease during staging of NSCLC.

View Article and Find Full Text PDF

Extranodal NK/T-cell lymphoma (ENKTCL) is an Epstein-Barr virus (EBV)-related neoplasm preferentially involving the upper aerodigestive tract. Here we show that NK-cell-specific Trp53 disruption in mice leads to the development of NK-cell lymphomas after long latency, which involve not only the hematopoietic system but also the salivary glands. Before tumor onset, Trp53 knockout causes extensive gene expression changes, resulting in immature NK-cell expansion, exclusively in the salivary glands.

View Article and Find Full Text PDF
Article Synopsis
  • * In mice with mutations in ciliary proteins, abnormal cranial neural crest-derived cells disrupt signaling pathways, leading to improper cell differentiation and subsequent tongue issues like ankyloglossia.
  • * The research also indicates that these tongue deformities can be artificially triggered in normal mice, suggesting potential avenues for treatment approaches in ciliopathies.
View Article and Find Full Text PDF

Multiple myeloma (MM) is a hematologic malignancy characterized by clonal proliferation of plasma cells. Recent advances in next-generation sequencing technologies have facilitated in-depth genetic exploration of MM, unveiling a more comprehensive genomic landscape that extends beyond classical chromosomal alterations, such as IGH translocations and hyperdiploidy. These studies have elucidated recurrent mutations across various functional pathways including those involving MAPK, NF-κB, cell cycle regulation, and epigenetic modulation.

View Article and Find Full Text PDF

Adult T-cell leukemia/lymphoma (ATLL) is an aggressive peripheral T-cell malignancy caused by human T-cell leukemia virus type-1 (HTLV-1) infection. Genetic alterations are thought to contribute to the pathogenesis of ATLL alongside HTLV-1 products such as Tax and HBZ. Several large-scale genetic analyses have delineated the entire landscape of somatic alterations in ATLL, which is characterized by frequent alterations in T-cell receptor/NF-κB pathways and immune-related molecules.

View Article and Find Full Text PDF

Introduction: Many patients with atrial fibrillation have impaired renal function, and therefore pre-operative CT for radiofrequency catheter ablation should minimize the use of contrast media. This study describes a dual-region-of-interest (D-ROI) protocol for the scanning of pulmonary veins and left atrium (PVs-LA) with less contrast media and optimized scan timing compared to the single-region-of-interest (S-ROI) protocol, without compromising image quality.

Methods: This study retrospectively included 100 patients who underwent PVs-LA CT between July 2019 and February 2022.

View Article and Find Full Text PDF

Background: Sarcopenia is characterized by reduced skeletal muscle volume and is a condition that is prevalent among elderly patients and associated with poor prognosis as a comorbidity in malignancies. Given the aging population over 80 years old in Japan, an understanding of malignancies, including colorectal cancer (CRC), complicated by sarcopenia is increasingly important. Therefore, the focus of this study is on a novel and practical diagnostic approach of assessment of psoas major muscle volume (PV) using 3-dimensional computed tomography (3D-CT) in diagnosis of sarcopenia in patients with CRC.

View Article and Find Full Text PDF

Background: Genetic polymorphisms of molecules are known to cause individual differences in the therapeutic efficacy of anticancer drugs. However, to date, germline mutations (but not somatic mutations) for anticancer drugs have not been adequately studied. The objective of this study was to investigate the association between germline polymorphisms of gemcitabine metabolic and transporter genes with carbohydrate antigen 19-9 (CA 19-9) response (decrease ≥50% from the pretreatment level at 8 weeks) and overall survival (OS) in patients with metastatic pancreatic cancer who receive gemcitabine-based chemotherapy.

View Article and Find Full Text PDF

A 22-year-old Vietnamese man was referred to our hospital owing to cough, dyspnea, and difficulty moving. The patient was diagnosed with community-acquired Panton-Valentine leukocidin-positive methicillin-resistant (MRSA) bacteremia and necrotizing pneumonia. Treatment involved vancomycin (VCM) and meropenem, and the MRSA bacteremia improved.

View Article and Find Full Text PDF

Extranodal NK/T-cell lymphoma (ENKTCL) is an Epstein-Barr virus (EBV)-related neoplasm with male dominance and a poor prognosis. A better understanding of the genetic alterations and their functional roles in ENKTCL could help improve patient stratification and treatments. In this study, we performed a comprehensive genetic analysis of 178 ENKTCL cases to delineate the landscape of mutations, copy number alterations (CNA), and structural variations, identifying 34 driver genes including six previously unappreciated ones, namely, HLA-B, HLA-C, ROBO1, CD58, POT1, and MAP2K1.

View Article and Find Full Text PDF

Thirteen new records of Goniasteridae showing mesophotic occurrence are presented, including a new species of Pseudoceramaster doto n. sp. from southern Japan and a new genus and species, Churaumiastra hoshi nov.

View Article and Find Full Text PDF
Article Synopsis
  • * Out of 51 patients with OIIA-LPD, 16 were found to have lung involvement, with a median age of 69. Various types of lesions were identified, and a significant portion of patients underwent bronchoscopic biopsies for diagnosis.
  • * The results showed a 31.3% incidence rate of lung OIIA-LPD, with an overall response rate of 71.4% to MTX withdrawal; however, chemotherapy was necessary for some
View Article and Find Full Text PDF
Article Synopsis
  • The study investigates how specific genetic mutations in circulating tumor DNA (ctDNA) impact the prognosis of patients with relapsed/refractory multiple myeloma (RRMM) undergoing treatment.
  • Researchers identified 24 mutations in bone marrow plasma cells (BMPC) and 47 in ctDNA from 261 RRMM cases, with certain mutations, especially in the TP53 gene, linked to worse progression-free survival (PFS).
  • A new prognostic index based on the number of ctDNA mutations, plasma DNA concentration, and clinical factors was developed, highlighting ctDNA's role as a superior predictor for patient outcomes compared to mutations found in BMPC.
View Article and Find Full Text PDF
Article Synopsis
  • * The artemis trial is a Phase II study testing a new chemotherapy regimen combining carboplatin, paclitaxel, lenvatinib, and pembrolizumab for patients with advanced or recurrent thymic carcinoma, involving 35 participants.
  • * The main goal of the trial is to measure the objective response rate, while also assessing progression-free survival and safety of the treatment options.
View Article and Find Full Text PDF

Bacteria utilize electron conduction in their communities to drive their metabolism, which has led to the development of various environmental technologies, such as electrochemical microbial systems and anaerobic digestion. It is challenging to measure the conductivity among bacterial cells when they hardly form stable biofilms on electrodes. This makes it difficult to identify the biomolecules involved in electron conduction.

View Article and Find Full Text PDF

Although prescription review is an important role for pharmacists in anticancer drug therapy, there are no guidelines in Japan that specify what pharmacists should check for in chemotherapy regimens. This prospective multicenter survey aimed to investigate the implementation of chemotherapy regimen checks by pharmacists in general hospitals by focusing on 19 recommended confirmation items designed to enhance chemotherapy safety. This study involved 14 hospitals within the National Hospital Organization in different regions of Japan.

View Article and Find Full Text PDF

Unlabelled: Using 48,627 samples from the Center for Cancer Genomics and Advanced Therapeutics (C-CAT), we present a pan-cancer landscape of driver alterations and their clinical actionability in Japanese patients. Comparison with White patients in Genomics Evidence Neoplasia Information Exchange (GENIE) demonstrates high TP53 mutation frequencies in Asian patients across multiple cancer types. Integration of C-CAT, GENIE, and The Cancer Genome Atlas data reveals many cooccurring and mutually exclusive relationships between driver mutations.

View Article and Find Full Text PDF
Article Synopsis
  • Dexamethasone is commonly used for preventing nausea and vomiting in chemotherapy patients but has notable side effects, leading to the exploration of a steroid-free antiemetic regimen.
  • The study evaluated the effectiveness and safety of a combination of palonosetron, aprepitant, and olanzapine in patients receiving cisplatin, finding a total control rate of 31.3% and complete response rates of 61.4%, 84.3%, and 65.1% in different phases.
  • While the primary endpoint wasn't met, the complete response rates were comparable to traditional regimens, suggesting this dexamethasone-free option could be beneficial for patients unable to use corticosteroids.
View Article and Find Full Text PDF

Human T-cell leukemia virus type 1 (HTLV-1) establishes chronic infection in humans and induces a T-cell malignancy called adult T-cell leukemia-lymphoma (ATL) and several inflammatory diseases such as HTLV-1-associated myelopathy/tropical spastic paraparesis (HAM/TSP). Persistent HTLV-1 infection is established under the pressure of host immunity, and therefore the immune response against HTLV-1 is thought to reflect the status of the disease it causes. Indeed, it is known that cellular immunity against viral antigens is suppressed in ATL patients compared to HAM/TSP patients.

View Article and Find Full Text PDF

Herein, we report the development of ruthenium-catalysed cross-coupling reaction of β-ketoamides as alkenyl electrophiles with organoboronates. This reaction presumably proceeds the cleavage of the alkenyl C-N bond of the β-enaminoamide, which is generated from the β-ketoamide and pyrrolidine, and is promoted by a nearby amide directing group and a ruthenium catalyst.

View Article and Find Full Text PDF
Article Synopsis
  • - Patients with EGFR-mutated non-small-cell lung cancer (NSCLC) who receive EGFR tyrosine kinase inhibitors like osimertinib tend to have longer survival compared to those without these mutations.
  • - The ongoing phase II clinical trial is examining how effective osimertinib, combined with platinum-based chemotherapy, is for preventing progression of brain lesions in NSCLC patients with EGFR mutations who show no disease progression in the brain after treatment.
  • - The trial's main focus is on progression-free survival, while secondary goals include overall survival, treatment response rates, and safety, as well as timelines for controlling CNS symptoms and potential whole-brain irradiation.
View Article and Find Full Text PDF